Innovative Molecules Targets Epstein-Barr Virus with New Drug Program
Munich-based Innovative Molecules is expanding its clinical-stage virology pipeline by launching a program centered on Epstein-Barr Virus (EBV) treatments. The company plans to transition its series of targeted polymerase inhibitors into Phase 1 human trials by 2027, aiming to address critical gaps in current antiviral care.
Innovative Molecules Targets Epstein-Barr Virus with New Antiviral Program
Munich-based clinical-stage biotech Innovative Molecules is expanding its focus on herpesvirus-mediated diseases, announcing a new antiviral program aimed at the Epstein-Barr virus. The company plans to move its novel, potent polymerase inhibitors into Phase 1 clinical trials by 2027 to address currently underserved patient populations.
Wuhan Positions Itself as a Global Hub for Youth Innovation
With the 2026 World Youth Development Forum currently underway, Wuhan is leveraging its status as a center for optical technology and academic research to court international talent. The city, home to over 10 million residents, is framing its rapid industrial evolution as a primary destination for the next generation of global entrepreneurs.
KBR Opens Bengaluru AI Hub to Scale Industrial Energy Solutions
In a move to anchor industrial AI development in India, KBR has inaugurated its first Innovation Studio in Bengaluru. Co-located with Applied Computing, the facility functions as a centralized hub for remote monitoring and advisory services, leveraging the INSITE 3.0 platform to serve KBR’s global energy clientele.
Shell Recharge and SINEXCEL Open Shenzhen R&D Hub
In a bid to reshape the electric vehicle charging landscape, Shell Recharge and SINEXCEL have inaugurated a joint laboratory in Shenzhen. The facility aims to bridge the gap between high-level power electronics and global energy retail, focusing on technical breakthroughs for both passenger fleets and heavy-duty transport infrastructure.